arrow
A

Axel Hauschild

university hospital schleswig-holstein (uksh)
H指数:110
被引数:7.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma

随机化EORTC-2139/COLUMBUS-AD试验的初步分析:辅助恩考拉芬尼和比尼替尼与安慰剂在高风险II期BRAF-V600E/K黑色素瘤中的比较

2026-07-210
PRE
Messages for ultraviolet-radiation protection to fair-skinned populations

关于紫外线防护的信息,面向肤色较浅的人群

2025-11-060
OAAI
Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma

基线D-二聚体作为cemiplimab治疗皮肤鳞状细胞癌疗效的预测标志物

2025-07-100
OA
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.

新辅助病灶内靶向免疫细胞因子(Daromun)在III期黑色素瘤中的应用。

2025-07-070
PREAI
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology

关于欧洲转移性黑色素瘤新型治疗方法可及性的最新进展——2024年欧洲黑色素瘤登记系统与欧洲皮肤肿瘤学会联合调查

2025-02-011
PRE
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWERCSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
2025-01-013
PRE
S2k guideline basal cell carcinoma of the skin (update 2023)
2024-12-080
OAAI
S2k guideline basal cell carcinoma of the skin (update 2023)
2024-11-250
OAAI
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care

使用人工智能改善患者护理中皮肤镜黑色素瘤诊断的前瞻性多中心研究

2024-09-112
OA
Neoadjuvant cemiplimab for stage IIeIV cutaneous squamous cell carcinoma (CSCC): 2-year follow-up and biomarker analyses

新辅助西米利单抗治疗IIeIV期皮肤鳞状细胞癌(CSCC):2年随访及生物标志物分析

2024-09-010
PRE
Patients' and dermatologists' preferences in artificial intelligenceedriven skin cancer diagnostics: A prospective multicentric survey study

患者和皮肤科医生在人工智能驱动的皮肤癌诊断中的偏好: 一项前瞻性多中心调查研究

2024-08-011
OAAI
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
2024-07-030
OAAI
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

皮肤癌是皮肤白皙人群中最常见的癌症,但我们可以预防它们。

2024-06-018
OA
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning
2024-05-011
OAAI
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy

通过基于组织的分析预测原发性皮肤黑色素瘤的前哨淋巴结风险,可能重新定义前哨淋巴结活检的必要性

2024-05-011
OAAI
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics
2024-03-0110
OAAI
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects

副作用注册表免疫肿瘤学 (SERIO) -一种用于对免疫疗法引起的副作用进行系统分析的工具

2024-03-015
PRE
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy

基于辅助PD-1的免疫治疗后复发黑色素瘤局部治疗后使用BRAF/MEK抑制剂的 “第二佐剂” 治疗的疗效和安全性

2024-03-014
PRE
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
2024-02-017
OA